Please login to the form below

Not currently logged in
Email:
Password:

managed access programmes

This page shows the latest managed access programmes news and features for those working in and with pharma, biotech and healthcare.

Clinigen acquires Idis for £225m

Clinigen acquires Idis for £225m

Idis supplies unlicensed medicines predominantly on an exclusive basis through managed access programmes as well as on demand via its general access division.

Latest news

  • Langland triumphs at IPA Best of Health Awards Langland triumphs at IPA Best of Health Awards

    In addition to picking up Best of Show, Langland's campaign for Idis – which develops managed access programmes – also won Best use of Art Direction and a Gold Award for Healthcare

  • Langland leads Global Award winners Langland leads Global Award winners

    I did this with Idis', an international campaign, was built around a series of documentary films designed to raise awareness of Idis' managed access programmes.

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Former Quintiles president Jeff Thomis to chair Idis Former Quintiles president Jeff Thomis to chair Idis

    Will oversee company’s activities to develop managed access programmes for medicines. ... Idis has appointed Jeff Thomis as chairman to oversee the company's activities in creating managed access programmes for medicines.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....